Immunogen Inc. Stock
Price
Target price
-
-
-
-
-
-
WKN: 878613 / Symbol: IMGN / Name: ImmunoGen / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Immunogen Inc. Stock
So far the community has only identified positive things for Immunogen Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Immunogen Inc. in the next few years
Pros
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immunogen Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Immunogen Inc. | - | - | - | - | - | - | - |
Evolus Inc | -3.360% | 5.109% | 20.000% | 68.421% | 59.116% | 114.925% | - |
Ardelyx Inc. | -3.940% | -1.625% | 0.453% | 36.215% | -7.855% | 371.327% | 20.280% |
Coherus Bioscien. | 1.760% | -20.402% | -16.557% | -77.568% | -68.750% | -93.667% | -95.188% |
Comments
ImmunoGen, Inc. (NASDAQ: IMGN) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $25.00 price target on the stock.
Show more
Ratings data for IMGN provided by MarketBeat
ImmunoGen, Inc. (NASDAQ: IMGN) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $22.00 price target on the stock, up previously from $9.00.
Show more
Ratings data for IMGN provided by MarketBeat
ImmunoGen, Inc. (NASDAQ: IMGN) had its price target raised by analysts at HC Wainwright from $26.00 to $27.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IMGN provided by MarketBeat